Mar. 31, 2023

daprodustat

oral, once-daily, pan-PHD inhibitor FDA-approved for anemia in CKD patients designed PHD cofactor mimetic FDA approval, February 1, 2023 GSK, PLC, London, UK

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in